You are on page 1of 28

6/8/23, 21:46 Diverticulitis - ClinicalKey

CLINICAL OVERVIEW  
Diverticulitis 
Elsevier Point of Care  (see details)
Updated May 1, 2023. Copyright Elsevier BV. All rights reserved.

Synopsis

Urgent Action
Hospitalize all patients with signs and symptoms of systemic illness, peritonitis, or
complicated disease

Immediate surgical consultation is necessary for patients with peritonitis,


complicated disease, or vascular catastrophe
Patients with perforated diverticulitis and diffuse peritonitis should undergo
emergent surgical intervention 1

Key Points
Diverticulitis involves microperforation of a diverticulum, with ensuing localized
inflammation contained by pericolic fat and mesentery

Constipation and a Western diet of highly refined, low-fiber foods are thought to be major
contributing factors to diverticulosis

Diagnosis of acute diverticulitis can usually be made on the basis of history and physical
examination

Lower left quadrant tenderness may be present, but right-sided signs do not preclude
diagnosis; low-grade fever is common

CT of abdomen/pelvis is the imaging test of choice for confirming the diagnosis

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 1/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Conservative (nonsurgical) management of uncomplicated diverticulitis, with or without


oral antibiotic therapy, results in resolution in most patients

All patients with complicated diverticulitis require treatment with oral or IV antibiotics

Patients who have severe or complicated diverticulitis or whose condition does not respond
to medical therapy often require surgical intervention

Pitfalls
Fever is often absent in older adults; a rectal temperature may be required for detection of
fever in this population 2

Older adults and some patients taking corticosteroids may have unremarkable findings,
even in the presence of severe diverticulitis 2

Right-sided diverticulitis is often confused with appendicitis

Terminology

Clinical Clarification
Diverticulosis involves saclike outpouchings of mucosa and submucosa through the
muscular layer of the colon 3

Diverticulitis involves microperforation of a diverticulum, with ensuing localized


inflammation contained by pericolic fat and mesentery; most common complication of
diverticulosis 4

Classification
Modified Hinchey classification for acute diverticulitis 5

Stage 0: clinically mild diverticulitis

Stage Ia: confined pericolic inflammation and phlegmonous inflammation

Stage Ib: abscess formation (less than 5 cm) in or near area of primary inflammatory
process

Stage II: intra-abdominal abscess, pelvic or retroperitoneal abscess, and/or abscess distant
from primary inflammatory process

Stage III: generalized purulent peritonitis


https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 2/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Stage IV: fecal peritonitis

Alternative classification systems such as the CDD (Classification of Diverticular Disease) 6


and DICA (Diverticular Inflammation and Complication Assessment) 7 have been advocated
by some authors but as yet have not replaced modified Hinchey classification

Acute complicated diverticulitis 8

Diverticulitis associated with any of the following:

Uncontained perforation with a systemic inflammatory response

Fistula

Abscess

Stricture

Obstruction

Acute uncomplicated diverticulitis 8 9

Inflammation in a diverticula‐bearing bowel segment and the surrounding tissue that is


not associated with perforation, fistula, abscess, stricture, or obstruction

Chronic diverticulitis 9

Colonic wall thickening or chronic mucosal inflammation may develop if acute


diverticulitis does not resolve completely
May be uncomplicated or complicated (involving stenosis, which may lead to acute bowel
obstruction, or fistula formation)

Diagnosis

Clinical Presentation

History
Acute lower left quadrant abdominal pain (most commonly); right-sided pain can occur in
some cases

More generalized abdominal pain may occur with peritonitis

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 3/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Constitutional symptoms

Fever

Chills

Other gastrointestinal symptoms

Nausea or vomiting

Abdominal mass

Constipation or diarrhea

Flatulence or bloating

Urinary symptoms (eg, dysuria, urgency, frequency) can occasionally occur


Rarely, there may be concurrent diverticular bleeding with blood in stool

Complicated diverticulitis presents with typical features of underlying pathology (eg,


abscess, fistula, obstruction, free perforation)

Physical examination
Lower left quadrant tenderness may be present, but right-sided signs do not preclude
diagnosis

Right-sided diverticulitis is often confused with appendicitis

Low-grade fever is common (may be absent in older adults [eg, those aged 65 years or older])
2

Signs of peritoneal inflammation (eg, muscle guarding, rebound tenderness) are absent with
uncomplicated diverticulitis

With peritonitis

Generalized tenderness with rebound and guarding on abdominal examination

Abdomen may be distended and tympanic to percussion

Bowel sounds may be diminished or absent

Older adults and some patients taking corticosteroids may have unremarkable findings,
even in the presence of severe diverticulitis 2

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 4/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Causes and Risk Factors

Causes
Segmental spasm of muscular coat of bowel causes anatomic and physiologic changes in
colon, contributing to development of diverticula (diverticulosis); changes lead to mucosal
extrusion at colon’s weakest points, adjacent to penetrating nutrient artery

Constipation and a Western diet of highly refined, low-fiber foods are thought to be major
contributing factors to diverticulosis; however, recently the role of dietary fiber has been
questioned 4

Diverticulitis develops owing to initial microperforation of a diverticulum

Process begins with blockage of colonic opening of diverticulum or by direct contact with
food and fecal particles lodged in affected section of bowel

Increased intraluminal or direct local pressure results in erosion of diverticular wall,


leading to inflammatory changes, focal necrosis, and perforation; process is typically mild
and limited by local pericolic fat and mesentery

Risk factors and/or associations

Age
More common with increasing age; less common before age 40 years (less than 10% of cases)
4

Some studies have suggested an increasing frequency of diverticular disease in younger


patients 6

Sex
In patients older than 50 years, acute diverticulitis occurs more frequently in females 1

In patients younger than 50 years, acute diverticulitis occurs more commonly in males 1

Genetics
40% to 50% of the risk for diverticulitis is attributable to genetic predisposition 10 11

Ethnicity/race
https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 5/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Diverticulosis is less common in non-Hispanic Black people and Asian/Pacific Islanders


compared with non-Hispanic White people 12

Other risk factors/associations


Most common in industrialized Western societies 13

In Western countries, left-sided diverticulosis is most common; however, in Asian countries,


diverticulosis is predominantly right-sided 4

Lifestyle factors implicated in development of diverticulitis 14

Obesity 13

Decreased physical activity 4


Alcohol consumption 4

Smoking 13

Aspirin and other NSAIDs 13

Immunosuppression and chronic corticosteroid use 12

Diets high in red meat 13

Consumption of particulate foods, such as nuts, popcorn, corn, and sunflower seeds, does
not contribute to the development of diverticulitis and may even have a potential protective
impact 14

Diagnostic Procedures

  Primary diagnostic tools


Diagnosis of acute diverticulitis can often be made on
the basis of history and physical examination,
although clinical diagnosis can be inaccurate 4

Laboratory tests may be of help when diagnosis is in


question Diverticulitis. - CT shows thickened
wall of the sigmoid colon (arrows)
WBC count, C-reactive protein, procalcitonin, and with stranding in the adjacent fat (*)
indicative of diverticulitis.
fecal calprotectin are potentially useful in predicting
severity of diverticulitis 8

Patients with tenderness in the left lower quadrant of


the abdomen, a C-reactive protein level greater than 50

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 6/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

mg/L, and no history of vomiting are highly likely to ha


diverticulitis (positive predictive value of 97%-100%) 15

CT of abdomen and pelvis is the imaging test of choice


8 15

A step-up approach with initial abdominal ultrasono


ultrasonography is inconclusive or negative has been
approach in cases of suspected acute diverticulitis 15

Selective imaging is recommended in patients with any

Pain localized to left lower quadrant


Absence of vomiting

C-reactive protein level greater than 50 mg/L

History of acute diverticulitis

Colonoscopy is not required to diagnose acute diverticu


an increased risk of perforation 6

  Laboratory

  Imaging

Differential Diagnosis

Most common
Inflammatory bowel disease (Related: Crohn Disease)

Inflammatory bowel disease includes Crohn disease and ulcerative colitis (Related:
Ulcerative Colitis)

Typically a chronic disorder marked by intermittent flares and relapses

Abdominal distention and tenderness

Bloody diarrhea, fever, and dehydration can be seen

Suspect Crohn disease with aphthous ulcers and perianal involvement

Differentiated by colonoscopy and biopsy confirming diagnosis

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 7/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Pyelonephritis (Related: Urinary Tract Infection in Adults)

Infection, usually bacterial in origin, of upper urinary tract

Patient may present with flank pain and costovertebral angle tenderness

Dysuria and polyuria

Pyuria noted on urinalysis

Differentiated by history, physical examination, and urine culture to identify causative


organisms

Colorectal cancer (Related: Colorectal Cancer)

Most common symptoms are rectal bleeding, abdominal pain, and change in bowel
habits

Abdominal examination may show a palpable mass, hepatomegaly, or distention due to


colonic obstruction or malignant ascites

A distal rectal lesion may be identified by digital rectal examination

Peritoneal implants in the cul-de-sac may be palpable with metastatic disease

Colonoscopy shows morphologic features suggesting malignant polyps (eg, irregular


contours; central depression; contact bleeding; shape deformity; flat sessile polyps or
raised pedunculated polyps; small, regularly spaced papules; abnormal vasculature or
surface pattern)

Differentiated by colonoscopy and biopsy confirming diagnosis

Ovarian cancer (Related: Ovarian Cancer)

May present with abdominal fullness and early satiety, pelvic and back pain, constipation,
or pelvic mass

Transvaginal ultrasonography may allow identification of abnormal masses

Differentiated by laparoscopy or laparotomy with histopathology, which provides


definitive diagnosis

Ischemic colitis

Inflammation of colon due to interruption of colonic blood supply

Associated with vascular or cardiovascular disease

Diarrhea with dark blood clots


https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 8/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Diffuse and poorly defined colonic tenderness with pain out of proportion to palpation

Fever and tachycardia, often in association with progressive hypotension and impending
sepsis

Differentiated by thumbprinting on barium enema

Pseudomembranous colitis

Characterized by diarrhea and bowel inflammation associated with antibiotic use (leading
to overgrowth of Clostridium difficile) (Related: Clostridioides difficile Infection)

History of antibiotic use

Abdominal tenderness, fever, and diarrhea

In symptomatic patients, perform stool testing for Clostridium difficile (only on diarrheal
samples)

Differentiated by history and stool testing positive for Clostridium difficile

Pelvic inflammatory disease (Related: Pelvic Inflammatory Disease)

Involves a range of inflammatory disorders of the upper genitourinary tract in females

Lower abdominal pain, vaginal discharge, and abnormal uterine bleeding

Dysuria and dyspareunia

Pain on manipulation of cervix


Adnexal tenderness or mass

Laparoscopy is gold standard for diagnosis; minimum criteria for diagnosis include tubal
wall edema, hyperemia of tubal surface, and exudate on tubal surfaces and fimbriae

Differentiated with laparoscopic confirmation of diagnosis

Endometriosis

Presence of functioning endometrial tissue outside the uterine cavity

Dysmenorrhea, dyspareunia, and infertility

Tender uterosacral ligaments

Cul-de-sac nodularity

Induration of rectovaginal septum


https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 9/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Obliteration of the cul-de-sac with fixed uterine retroversion can be seen in some
patients with extensive disease

Adnexal mass

Differentiated by laparoscopy showing endometrial tissue outside the uterine cavity

Appendicitis

Inflammation of the appendix; most common in younger patients

Often confused with right-sided diverticulitis

Gradual onset of dull periumbilical pain that localizes in right lower quadrant of
abdomen within 12 to 48 hours

Most sensitive symptoms are vomiting, fever (higher than 37.3 °C), and right lower
quadrant pain

Rebound tenderness with voluntary or involuntary guarding is usually present

Right lower quadrant pain on palpation of left lower quadrant (Rovsing sign) may be
noted

Psoas sign (pain aggravated by right thigh extension) may be noted

CT with contrast enhancement shows enlarged appendix (ie, appendix diameter more
than 6 mm in adults)

Differentiated by history, physical examination, and CT

Irritable bowel syndrome (Related: Irritable Bowel Syndrome)

Functional disorder involving abdominal pain and altered bowel habits without a specific
organic pathosis

Commonly involves nonspecific abdominal tenderness, often in lower left quadrant

Physical examination findings are normal

Loose stools, often in the morning and after meals, alternating with constipation

Differentiated by clinical history

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 10/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Treatment

Goals
Control symptoms

Manage related complications

Disposition

Admission criteria
Admit patients with signs and symptoms of systemic illness, peritonitis, or complicated
disease
Admission is also recommended for patients who require parenteral narcotic analgesia, who
are unable to tolerate oral hydration, or whose outpatient therapy has failed

Criteria for ICU admission


Patients with severe diverticular bleeding who are hemodynamically unstable

Patients with sepsis or septic shock

Patients undergoing surgical treatment may require ICU admission

Recommendations for specialist referral


Obtain immediate surgical consultation for patients with peritonitis, complicated disease,
or vascular catastrophe

Refer to a gastroenterologist for uncomplicated diverticulitis or noncatastrophic diverticular


bleeding

Treatment Options
Patients with uncomplicated diverticulitis can usually be managed conservatively as
outpatients, with or without oral antibiotic therapy 5

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 11/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Recent evidence has suggested an uncertain benefit of antibiotics for acute uncomplicated
diverticulitis, and as a result, many professional organizations no longer recommend
routine use 19 20 21

American Society of Colon and Rectal Surgeons and the American College of Physicians
have stated that selected, otherwise healthy patients with early-stage uncomplicated
diverticulitis can be treated without antibiotics 8 18

Most of these patients can be managed as outpatients with medical supervision 18

Antibiotic therapy is appropriate for patients with significant comorbidities, signs of


systemic infection, or immunosuppression and those beyond early-stage disease 8
Guidelines from the European Society of Coloproctology and the World Society of
Emergency Surgery recommend against routine antibiotic therapy for immunocompetent
patients with acute uncomplicated diverticulitis and no signs of systemic inflammation 9 15
17

Reserve antibiotic treatment for immunocompromised patients and patients with sepsis

Guidelines from the American Gastroenterological Association recommend that antibiotics


can be used selectively rather than routinely in immunocompetent patients with mild,
uncomplicated diverticulitis 11

Antibiotic treatment is advisable for patients who have comorbidities, refractory


symptoms or vomiting, or a C-reactive protein greater than 140 mg/L or baseline WBC
count greater than 15 × 109 cells/L, and for those who are frail

Also recommended in cases of uncomplicated diverticulitis associated with a fluid


collection or long segment of inflammation on CT scan

Outpatient treatment of mild uncomplicated diverticulitis typically consists of either an oral


fluoroquinolone or trimethoprim-sulfamethoxazole plus metronidazole, or oral
amoxicillin-clavulanate monotherapy (preferred owing to potential adverse effects with
fluoroquinolones) 11 22

Duration of antibiotic treatment, when given, is typically 3 to 7 days but can be longer
depending on patient's health status, severity of illness, and CT findings 11 23

Treat all patients with complicated diverticulitis with oral or IV antibiotics, depending on
severity 9 11 24

Oral first-, second-, and third-generation cephalosporins in combination with


metronidazole are potential options, because they have reasonable activity against non–
extended-spectrum β-lactamase–producing strains of Escherichia coli 25

Hospitalization and treatment with IV antibiotics are indicated for patients with
perforation, large abscesses, sepsis, or bowel obstruction, serious comorbidities, or an
https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 12/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

inability to tolerate oral liquid 24

Effective antibiotic regimens should cover typical enteric gram-negative organisms along
with anaerobic flora, 1 especially if there is a concurrent abscess

For patients with moderate disease, options include combination therapy with either a
fluoroquinolone, cefotaxime, or ceftriaxone plus metronidazole or monotherapy with
ertapenem, or moxifloxacin 24 25

In severely ill patients, options include meropenem monotherapy, imipenem-cilastatin,


piperacillin-tazobactam, or doripenem monotherapy, or combination therapy with either
cefepime, ceftazidime, or a fluoroquinolone plus metronidazole 24 25

Duration of antibiotic treatment, when given, is typically 4 to 7 days, providing source


control is achieved; can be longer depending on patient's health status, severity of illness,
and CT findings 24
Antibiotic treatment alone is recommended for abscesses smaller than 3 cm (the American
Society of Colon and Rectal Surgeons and the European Society of Coloproctology) 9 8 or for
those smaller than 4 to 5 cm (the World Society of Emergency Surgery) 1 17

Percutaneous drainage is indicated in addition to antibiotic therapy for patients with larger
abscesses

If percutaneous drainage of the abscess is not feasible or unavailable, antibiotics can be


considered the primary treatment unless emergency surgery is required 15

Nonoperative management of acute diverticulitis with abscess (IV antibiotics, NPO,


percutaneous drainage) has a failure rate of 21.8% 26

Consider elective colectomy after successful treatment of diverticular abscess, particularly if


abscess was larger, located pelvically, or required percutaneous drainage, because recurrence
is common

For treatment of segmental colitis associated with diverticular disease, consider a combination
of ciprofloxacin and metronidazole with mesalamine 10

Treatment course is prolonged

In severe cases, systemic corticosteroids may be required

Emergent or elective surgical intervention may be required

Patients with severe or complicated diverticulitis who are acutely ill, appear toxic, or whose
condition does not respond to medical therapy often require urgent surgical intervention 8

Patients with perforated diverticulitis and diffuse peritonitis should undergo emergent
surgical intervention 1

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 13/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Open surgical approach is recommended for generalized peritonitis with septic shock 27

Laparoscopic approach may be an alternative for hemodynamically stable patients 27 28


29

Surgical approach depends on patient's health status and severity of disease. May include
the following: 27 30

Primary resection and anastomosis (with or without a diverting stoma) in clinically


stable patients with no comorbidities 15

Hartmann procedure in patients who are critically ill or have multiple major
comorbidities 15
Laparoscopic peritoneal lavage and drainage in patients with purulent peritonitis only
(not for patients with fecal peritonitis and controversial)

Nonrestorative resection of the affected segment of the colon 15

Damage control strategy may be useful in patients who are extremely ill with
abdominal sepsis. Consists of initial surgery to remove source of sepsis, with
subsequent anatomical restoration of the gastrointestinal tract after a period of
recovery 15

Elective colectomy is generally recommended for all patients who have recovered from
complicated diverticulitis; however, some experts now suggest a more conservative and
individualized approach that may be reasonable 8 11

For patients with uncomplicated diverticulitis, individualize decisions about elective


segmental colectomy based on patient and presentation; not recommended based on
number of recurrences alone 11 31

Not generally recommended before a third episode of uncomplicated diverticulitis 12

Recommended for patients who are immunosuppressed and at risk of serious


complications or death from recurrent attacks of diverticulitis 8

Drug therapy
Penicillins

Piperacillin-tazobactam

May be used for empiric therapy in adults and children, but reserve for higher-risk
patients because of its broader-spectrum antimicrobial activity 25

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 14/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Piperacillin Sodium, Tazobactam Sodium Solution for injection; Adults: 3.375 g (3 g


piperacillin and 0.375 g tazobactam) IV every 4 to 6 hours or 4.5 g (4 g piperacillin and
0.5 g tazobactam) IV every 6 hours for 3 to 7 days.

Amoxicillin-clavulanate 32

For mild cases and patients tolerating oral intake and as step-down to complete
therapy

Amoxicillin Trihydrate, Clavulanate Potassium Oral tablet; Adults: 875 mg amoxicillin


with 125 mg clavulanate PO every 12 hours or 500 mg amoxicillin with 125 mg
clavulanate PO every 8 hours for a total treatment duration of 3 to 7 days.
Trimethoprim-sulfamethoxazole 32

For mild cases and patients tolerating oral intake

Sulfamethoxazole, Trimethoprim Oral tablet; Adults: 160 mg trimethoprim/800 mg


sulfamethoxazole PO twice daily with metronidazole.

Cephalosporins

All may be used in combination with metronidazole for initial empiric therapy for lower-
risk patients 25

Cefotaxime

Cefotaxime Sodium Solution for injection; Adults: 1 to 2 g IV every 6 to 8 hours for 3 to


7 days.

Ceftriaxone

Ceftriaxone Sodium Solution for injection; Adults: 1 to 2 g IV/IM every 12 to 24 hours


for 3 to 7 days.

Quinolones

Ciprofloxacin

May be used in combination with metronidazole for initial empiric therapy for lower-
risk patients with serious β-lactam allergies 25

IV dosing

Ciprofloxacin Solution for injection; Adults: 400 mg IV every 8 to 12 hours for 3 to 7


days.

Oral dosing

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 15/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Ciprofloxacin Hydrochloride Oral tablet; Adults: 500 mg PO every 12 hours for 3 to 7


days.

Moxifloxacin

May be used for initial empiric therapy for lower-risk patients with serious β-lactam
allergies 25

IV dosing

Moxifloxacin Hydrochloride Solution for injection; Adults: 400 mg IV every 24


hours for 3 to 7 days.

Oral dosing
Moxifloxacin Hydrochloride Oral tablet; Adults: 400 mg PO every 24 hours for 3 to 7
days.

Carbapenems

Ertapenem

May be used as monotherapy for initial empiric therapy for lower-risk patients 25

Ertapenem Solution for injection; Adults: 1 g IV once daily for 3 to 7 days.

Imipenem-cilastatin

Imipenem, Cilastatin Sodium Solution for injection; Adults: 500 mg IV every 6 hours
or 1 g IV every 8 hours for fully susceptible organisms and 1 g IV every 6 hours for
organisms with intermediate susceptibility. Treat for 3 to 7 days.

Aztreonam

For empiric treatment of infections in which enteric gram-negative bacteria may play a
role

Aztreonam plus metronidazole plus vancomycin can be used as an option for higher-risk
patients with a severe reaction to β-lactam agents 25

Aztreonam Solution for injection; Adults: 1 to 2 g IV every 6 to 8 hours for 3 to 7 days.


Metronidazole

Active against anaerobic flora of gastrointestinal tract

Provides effective treatment when used in conjunction with an agent active against gram-
negative enteric bacteria
https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 16/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

IV dosing

Metronidazole Solution for injection; Adults: 500 mg IV every 6 to 12 hours or 1.5 g IV


every 24 hours for 3 to 7 days.

Oral dosing

Guidelines suggest as part of combination step-down oral therapy with a second- or


third-generation cephalosporin or a fluoroquinolone

Metronidazole Oral tablet; Adults: 500 mg PO every 6 hours for 3 to 7 days.

Vancomycin

Aztreonam plus metronidazole plus vancomycin can be used as an option for higher-risk
patients with a severe reaction to β-lactam agents 25

Vancomycin Hydrochloride Solution for injection; Adults: 20 to 35 mg/kg/dose (Max:


3,000 mg/dose) IV loading dose, followed by 15 to 20 mg/kg/dose IV every 8 to 12 hours;
adjust dose based on target PK/PD parameter. Consider loading dose in critically ill
patients. Treat for 3 to 7 days.

Vancomycin Hydrochloride Solution for injection; Obese Adults: 20 to 25 mg/kg/dose


(Max: 3,000 mg/dose) IV loading dose, followed by 15 to 20 mg/kg/dose IV every 8 to 12
hours (Usual Max: 4,500 mg/day); adjust dose based on target PK/PD parameter. Consider
loading dose in critically ill patients. Treat for 3 to 7 days.

Mesalamine

May be used for segmental colitis associated with diverticular disease, in combination
with ciprofloxacin and metronidazole

Mesalamine Oral capsule, extended-release; Adults: 800 to 3,000 mg/day PO as a single


dose or in divided doses.

Nondrug and supportive care


Diet
No evidence to support dietary restrictions in uncomplicated diverticulitis; unrestricted diet
as tolerated may be preferable 9

Clear liquid diet for 2 to 3 days is reasonable for patient comfort during the acute phase;
advanced to low-fiber diet as tolerated 11 24

Patients with severe complicated diverticulitis should have no oral intake until condition
has stabilized 24

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 17/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Maintenance of hydration 5

Particularly in patients with dehydration, peritonitis, complicated disease, or significant


bleeding

Pain relief 24

Acetaminophen and antispasmodics are first line analgesics

Avoid NSAIDs in patients with acute diverticulitis, because they are associated with risk of
diverticulitis and complicated diverticulitis 33

Avoid opioid narcotics, if possible, because they are associated with increased risk of
perforated diverticulitis

Procedures

CT-guided percutaneous drainage

General explanation
CT-guided needle aspiration of abscesses, followed by Gram stain and culture of aspirate

Indication
Drainage of diverticulitis complicated by abscess formation

Consider for peridiverticular abscess larger than 3 to 5 cm in diameter (threshold varies by


organization), those that do not resolve with antibiotics, or when in the presence of patient
deterioration 1 8 9 17

Contraindications
Bleeding disorders; limited data regarding safety

Complications
Iatrogenic injury to adjacent organs

Extending infected material into noninfected tissue

Inadequate removal of infected material

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 18/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Interpretation of results
Modify antibiotic regimen as needed based on culture results

Laparoscopic surgery

General explanation
Laparoscopic colonic resection and primary reanastomosis

Benefits of laparoscopy include decreased pain, decreased wound infection rate, 34


decreased blood loss, and shorter length of hospital stay, 34 although intraoperative
procedure time is longer; long-term benefits are unclear 5

Indication
Recurrent uncomplicated diverticulitis that is well localized and significantly resolved from
the acute state

Laparoscopic approach is recommended in elective surgery for diverticular disease, when


feasible 1

Contraindications
Coagulopathy

Fulminant colitis

Critical colonic distention

Complications
Anastomotic leakage

Ileus

Laparotomy with sigmoid resection 31

General explanation
Resection of the diseased colon is accompanied by creation of an end colostomy and a rectal
stump; Hartmann procedure is commonly used

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 19/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Indication
Complicated diverticulitis or multiple episodes of uncomplicated diverticulitis

Failed percutaneous drainage of clinically relevant abscesses, enterocutaneous fistulas, and


bowel obstruction

Exploratory laparotomy is considered to be the final therapeutic modality

Contraindications
Contraindications to primary anastomosis are fecal or purulent peritonitis, severe comorbid
conditions (including uncorrected bleeding dyscrasia), poor nutrition, and
immunosuppression

Complications
Ileus

Comorbidities
Immunocompromised status

Transplant recipients and patients with chronic diseases affecting the immune system are
at increased risk of more aggressive and complicated diverticulitis 5

Those with impaired inflammatory response may have only extraluminal gas on CT
without other typical radiographic findings of diverticulitis

Monitoring
Follow up 4 to 6 weeks after resolution of symptoms of an episode of diverticulitis or after
surgical treatment

Arrange follow-up colonoscopy to exclude occult malignancy unless patient has had one
within past year 11 35 36
Colonoscopy is recommended after any episode of acute complicated diverticulitis 8 11

Prevalence of colorectal cancer is 7.9% to 10.8% in patients diagnosed with


complicated diverticulitis 14

Also obtain in patients who report ongoing symptoms (bleeding, changed bowel habits,
ongoing pain) after an episode of uncomplicated acute diverticulitis 9

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 20/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

May not be necessary for patients with symptom‐free recovery after a single episode of
CT-verified uncomplicated diverticulitis when patient has no signs of colorectal cancer,
such as anemia, hematochezia, or change in bowel habit, and where the symptoms of
diverticulitis are resolving at 4-week follow-up 9 14 37

Arrange colonoscopy at least 6 to 8 weeks after an episode of acute complicated


diverticulitis has resolved or symptoms have fully resolved (whichever is longer) 8 9 11

Complications and Prognosis

Complications
Diverticular bleeding

Intestinal abscess

Intestinal fistula

Colovesical fistula (most common)

External large bowel fistula

Enterocolic fistula
Intestinal obstruction/stricture 4

Peritonitis 5

Sepsis 5

Septic shock

Segmental colitis

Pyogenic liver abscesses

Prognosis
Outpatient management is successful in 94% to 97% of patients 4

Approximately 15% to 20% of patients with diverticulitis develop complications 4

Approximately 15% to 30% of patients who are hospitalized for acute diverticulitis require
surgical intervention 4

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 21/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Risk of recurrent symptoms after acute diverticulitis ranges from 7% to 45%; half of
recurrences occur within 1 year 12

Risk for recurrent disease increases with each subsequent episode of acute diverticulitis

Recurrence of diverticulitis is more likely after an episode of complicated diverticulitis


managed without surgery than after an episode of uncomplicated diverticulitis

Screening and Prevention

Prevention
After an episode of diverticulitis, advise patients on the following secondary prevention
measures:

High-fiber diet 38 5

Adequate exercise 5  appropriate to age

Smoking cessation and limited intake of alcohol and red meat (Related: Tobacco Use
Disorder and Smoking Cessation) 5

Weight loss if overweight 8


Avoid regular use of NSAIDs (except aspirin for secondary prevention of cardiovascular
disease) 11 33

Evidence does not support the dietary exclusion of whole pieces of fiber (eg, nuts, corn,
seeds) 11 13

Consider elective prophylactic surgical resection to prevent recurrences after acute


diverticulitis in patients with uncomplicated diverticulitis that is persistent or recurs
frequently or in patients with complicated diverticulitis 35 39

Consider on a case-by-case basis, taking into account the severity of diverticulitis,


patient's health status and preferences, and benefits and risks of surgery

Some experts suggest prophylactic segmental resection of the colon to prevent recurrence
after an episode of complicated diverticulitis 12

Prophylactic surgery may be considered after a third episode of uncomplicated


diverticulitis to prevent further recurrences 12

Rifaximin has been advocated as a possible option for secondary prevention of recurrent
acute diverticulitis; not routinely recommended 40
https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 22/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

Mesalamine is not recommended to prevent recurrent diverticulitis 35

References
1. Francis NK et al: EAES and SAGES 2018 consensus conference on acute diverticulitis management:
evidence-based recommendations for clinical practice. Surg Endosc. 33(9):2726-41, 2019
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-1) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/31250244)

2. Fugazzola P et al: The WSES/SICG/ACOI/SICUT/AcEMC/SIFIPAC guidelines for diagnosis and


treatment of acute left colonic diverticulitis in the elderly. World J Emerg Surg. 17(1):5, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-2) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/35063008)

3. Ghahremani GG: Intramural diverticulosis and diverticulitis of the colon: pictorial essay. Clin
Imaging. 81:150-6, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-3) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/34743065)

4. Bhuket TP et al: Diverticular disease of the colon. In: Feldman M et al, eds: Sleisenger and Fordtran's
Gastrointestinal and Liver Disease. 11th ed. Elsevier; 2021:1993-2007.e5
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-4)

5. Andeweg CS et al: Guidelines of diagnostics and treatment of acute left-sided colonic diverticulitis.
Dig Surg. 30(4-6):278-92, 2013
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-5) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/23969324)

6. Kruis W et al: German guideline diverticular disease/diverticulitis: Part I: methods, pathogenesis,


epidemiology, clinical characteristics (definitions), natural course, diagnosis and classification. United
European Gastroenterol J. 10(9):923-939, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-6) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/36411504)

7. Tursi A et al: Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in
predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort
study. Gut. 71(7):1350-8, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-7) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/34702716)

8. Hall J et al: The American Society of Colon and Rectal Surgeons clinical practice guidelines for the
treatment of left-sided colonic diverticulitis. Dis Colon Rectum. 63(6):728-47, 2020
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 23/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

2e76777823b3#inline-reference-8) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/32384404)

9. Schultz JK et al: European Society of Coloproctology: guidelines for the management of diverticular
disease of the colon. Colorectal Dis. 22 Suppl 2:5-28, 2020
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-9) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/32638537)

10. Tursi A et al: International consensus on diverticulosis and diverticular disease. Statements from the
3rd international symposium on diverticular disease. J Gastrointestin Liver Dis. 28(suppl 4):57-66,
2019
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-10) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/31930220)

11. Peery AF et al: AGA clinical practice update on medical management of colonic diverticulitis: expert
review. Gastroenterology. 160(3):906-11.e1, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-11) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33279517)

12. Peery AF: Management of colonic diverticulitis. BMJ. 372:n72, 2021


View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-12) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33762260)

13. Feuerstein JD et al: Diverticulosis and diverticulitis. Mayo Clin Proc. 91(8):1094-104, 2016
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-13) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/27156370)

14. Chabok A et al: Changing paradigms in the management of acute uncomplicated diverticulitis. Scand J
Surg. 110(2):180-6, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-14) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33934672)

15. Sartelli M et al: WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-
abdominal infections. World J Emerg Surg. 16(1):49, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-15) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/34563232)

16. Mäkelä JT et al: The role of C-reactive protein in prediction of the severity of acute diverticulitis in an
emergency unit. Scand J Gastroenterol. 50(5):536-41, 2015
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-16) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/25665622)

17. Sartelli M et al: 2020 update of the WSES guidelines for the management of acute colonic diverticulitis
in the emergency setting. World J Emerg Surg. 15(1):32, 2020
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-17) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/32381121)

18. Qaseem A et al: Diagnosis and management of acute left-sided colonic diverticulitis: a clinical
guideline from the American College of Physicians. Ann Intern Med. ePub, 2022
https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 24/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-


2e76777823b3#inline-reference-18) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/35038273)

19. van Dijk ST et al: Observational versus antibiotic treatment for uncomplicated diverticulitis: an
individual-patient data meta-analysis. Br J Surg. 107(8):1062-9, 2020
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-19) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/32073652)

20. Mege D et al: Meta-analyses of current strategies to treat uncomplicated diverticulitis. Dis Colon
Rectum. 62(3):371-8, 2019
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-20) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/30570549)

21. Dichman ML et al: Antibiotics for uncomplicated diverticulitis. Cochrane Database Syst Rev.
6(6):CD009092, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-21) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/35731704)

22. Gaber CE et al: Comparative effectiveness and harms of antibiotics for outpatient diverticulitis : two
nationwide cohort studies. Ann Intern Med. ePub, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-22) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33617725)

23. Chabok A et al: Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg.
99(4):532-9, 2012
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-23) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/22290281)

24. Swanson SM et al: Acute colonic diverticulitis. Ann Intern Med. 168(9):ITC65-C80, 2018
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-24) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/29710265)

25. Mazuski JE et al: The Surgical Infection Society revised guidelines on the management of intra-
abdominal infection. Surg Infect (Larchmt). 18(1):1-76, 2017
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-25) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/28085573)

26. Fowler H et al: Failure of nonoperative management in patients with acute diverticulitis complicated
by abscess: a systematic review. Int J Colorectal Dis. 36(7):1367-83, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-26) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33677750)

27. Nascimbeni R et al: Management of perforated diverticulitis with generalized peritonitis. A


multidisciplinary review and position paper. Tech Coloproctol. 25(2):153-65, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-27) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33155148)

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 25/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

28. Santos A et al: Comparing laparoscopic elective sigmoid resection with conservative treatment in
improving quality of life of patients with diverticulitis: the Laparoscopic Elective Sigmoid Resection
Following Diverticulitis (LASER) randomized clinical trial. JAMA Surg. 156(2):129-36, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-28) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33206182)

29. Azhar N et al: Laparoscopic lavage vs primary resection for acute perforated diverticulitis: long-term
outcomes from the Scandinavian Diverticulitis (SCANDIV) randomized clinical trial. JAMA Surg.
156(2):121-7, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-29) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33355658)

30. Tartaglia D et al: Damage control surgery for perforated diverticulitis with diffuse peritonitis: saves
lives and reduces ostomy. World J Emerg Surg. 14:19, 2019
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-30) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/31015859)

31. Regenbogen SE et al: Surgery for diverticulitis in the 21st century: a systematic review. JAMA Surg.
149(3):292-303, 2014
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-31) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/24430164)

32. Salzman H et al: Diverticular disease: diagnosis and treatment. Am Fam Physician. 72(7):1229-34, 2005
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-32) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/16225025)

33. Longo S et al: Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of
complications of diverticular disease: a meta-analysis of case-control and cohort studies. Int J
Colorectal Dis. 37(3):521-9, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-33) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/35094111)

34. Wu KL et al: Laparoscopic versus open surgery for diverticulitis: a systematic review and meta-analysis.
Dig Surg. 34(3):203-15, 2017
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-34) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/27941315)

35. Qaseem A et al: Colonoscopy for diagnostic evaluation and interventions to prevent recurrence after
acute left-sided colonic diverticulitis: a clinical guideline from the American College of Physicians.
Ann Intern Med. ePub, 2022
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-35) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/35038270)

36. Tehranian S et al: Prevalence of colorectal cancer and advanced adenoma in patients with acute
diverticulitis: implications for follow-up colonoscopy. Gastrointest Endosc. 91(3):634-40, 2020
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-36) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/31521778)

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 26/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

37. Laurie BD et al: Colonoscopy follow-up for acute diverticulitis: a multi-centre review. Surg Endosc.
37(3):1756-60, 2023
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-37) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/36220990)

38. Aune D et al: Dietary fibre intake and the risk of diverticular disease: a systematic review and meta-
analysis of prospective studies. Eur J Nutr. 59(2):421-32, 2020
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-38) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/31037341)

39. Khan A et al: Challenging surgical dogma: controversies in diverticulitis. Surg Clin North Am.
101(6):967-80, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-39) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/34774275)

40. Hanna MH et al: Update on the management of sigmoid diverticulitis. World J Gastroenterol.
27(9):760-81, 2021
View In Article (https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-
2e76777823b3#inline-reference-40) | Cross Reference (https://pubmed.ncbi.nlm.nih.gov/33727769)

  (https://play.google.com/store/apps/details?id=com.elsevier.cs.ck&hl=en)
  (https://itunes.apple.com/us/app/clinicalkey/id1041998175)   (https://www.facebook.com/ClinicalKey)
  (https://www.linkedin.com/company/3969981)   (https://www.twitter.com/ClinicalKey)

(http://www.elsevier.com/)

Contact Us (https://service.elsevier.com/app/contact/supporthub/clinicalkey/)

Resource Center (https://elsevierresources.com/clinicalkey/resource-centers/)

Terms & Conditions (https://www.elsevier.com/legal/elsevier-website-terms-and-conditions)

Privacy Policy (https://www.elsevier.com/legal/privacy-policy)

Registered User Agreement (http://www.elsevier.com/legal/elsevier-registered-user-agreement)

Help (https://service.elsevier.com/app/home/supporthub/clinicalkey/)

Accessibility (https://service.elsevier.com/app/answers/detail/a_id/19138/c/10546/supporthub/clinicalkey/)

(https://www.elsevier.com/legal/elsevier-website-terms-and-conditions)

(http://www.elsevier.com/legal/privacy-policy)

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 27/28
6/8/23, 21:46 Diverticulitis - ClinicalKey

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of
cookies (http://www.elsevier.com/legal/use-of-cookies).
Copyright © 2023 Elsevier B.V. or its licensors or contributors.

(http://www.relx.com/)

https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-3d31d58f-e815-4526-9f26-2e76777823b3 28/28

You might also like